Kullanma Önerisi

Uygulama sayısı ihtiyaç duyulduğu kadar olabilir.
Genelde günde 2-3 kezdir.
Özellikle banyodan sonra uygulanması tavsiye edilir

 

Referanslar: 1. Atopiclair® ürün bilgisi. 2. Handout on Health: atopic dermatitis. By National Institute of Health, department of health and Human services. 2009. http: //www.niams.nih.gov/Health_Info/atopic_dermatitis/ default.asp#o-. Son erişim tarihi: 31 Temmuz, 2013. 3. Atopic eczema in children management of atopic eczema in children from birth up to the age of 12 years. National Institute for Health and Clinical Excellence-Clinical Guidelines 2007. http://www.nice.org.uk/nicemedia/pdf/CG057FullGuideline.pdf. Son erişim tarihi: 3 Ağustos 2013. 4. Boguniewicz M, et al. MAS063DP is effective monotherapy for mild to moderate atopic dermatitis 
in infants and children: A multicenter, randomized, vehicle-controlled study. J Pediatri 2008;152:854-59. 5. Abramovits W, et al. A multicenter, randomized, vehicle-controlled clinical study to examine the 
efficacy and safety of MAS063DP (Atopiclair®) in the management of mild to moderate atopic 
dermatitis in adults. J Drugs Dermatol 2006; 5(3):236-44.


image


Atopiclair® ve Sebclair® dermatologlar ve pediatristler tarafından onaylanmaktadır.